Standard BioTools Inc. Income (Loss) from Continuing Operations, Per Basic Share
Standard BioTools Inc. (LAB) reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.06 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2026-08-05
- Standard BioTools Inc. income (loss) from continuing operations, per basic share for the quarter ending 2026-06-30 was -$0.06.
- Standard BioTools Inc. income (loss) from continuing operations, per basic share for the quarter ending 2026-03-31 was -$0.04.
- Standard BioTools Inc. income (loss) from continuing operations, per basic share for the quarter ending 2025-09-30 was -$0.08.
- Standard BioTools Inc. income (loss) from continuing operations, per basic share for the quarter ending 2025-06-30 was -$0.05.
- Standard BioTools Inc. income (loss) from continuing operations, per basic share for fiscal 2025 was -$0.15.
- Standard BioTools Inc. income (loss) from continuing operations, per basic share for fiscal 2024 was -$0.39.
- Standard BioTools Inc. income (loss) from continuing operations, per basic share for fiscal 2023 was -$0.94.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.06 10-Q · filed 2026-08-05 | -$0.09 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | -$0.04 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | -$0.15 10-K · filed 2026-03-16 | |||
| 2025-09-30 | -$0.08 10-Q · filed 2025-11-04 | -$0.19 10-Q · filed 2025-11-04 | ||
| 2025-06-30 | -$0.05 10-Q · filed 2026-08-05 | -$0.11 10-Q · filed 2026-08-05 | ||
| 2025-03-31 | -$0.06 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | -$0.39 10-K · filed 2026-03-16 | |||
| 2024-09-30 | -$0.06 10-Q · filed 2025-11-04 | -$0.32 10-Q · filed 2025-11-04 | ||
| 2024-06-30 | -$0.07 10-Q · filed 2025-08-15 | -$0.26 10-Q · filed 2025-08-15 | ||
| 2023-12-31 | -$0.94 10-K · filed 2026-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |